Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Link to SEPIO compliant JSON-LD document

Variant: NM_004985.5(KRAS):c.-160A>G

CA176498

163771 (ClinVar)

Gene: KRAS

Condition: RASopathy

Inheritance Mode: Autosomal dominant inheritance

Link to MONDO

UUID: 314b9d63-58ac-4c72-a617-acc0ca7dfa74

HGVS expressions

NM_004985.5:c.-160A>G

NM_004985.5(KRAS):c.-160A>G

NM_004985.4:c.-160A>G

NM_033360.3:c.-160A>G

ENST00000311936.7:c.-160A>G

ENST00000556131.1:c.-147A>G

ENST00000557334.5:c.-160A>G

NC_000012.12:g.25250899T>C

CM000674.2:g.25250899T>C

NC_000012.11:g.25403833T>C

CM000674.1:g.25403833T>C

NC_000012.10:g.25295100T>C

NG_007524.1:g.5022A>G

Benign

BA1 BP4 BP7

Evidence Links 0

Expert Panel

RASopathy VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

RASopathy VCEP

The c.-160A>G variant in KRAS is classified as benign because it has been identified in 0.22088% (95% CI of 27/8628) of African alleles in gnomAD (BA1; https://gnomad.broadinstitute.org). This variant is not located within the splice consensus sequence and computational splice site prediction tools do not predict an impact on splicing (BP4, BP7). ACMG/AMP Criteria applied: BA1, BP4, BP7.

BA1

Present in 0.22088% (95% CI of 27/8628) of African alleles in gnomAD

BP4

Splicing not predicted to be impacted by Alamut. Conservation data not applicable. REVEL score not provided.

BP7

Variant is outside of the splice consensus sequence and Alamut predicts no impact to splicing.

Approved on: 2019-11-04

Published on: 2019-11-04

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.